Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resveratrol and Pharmaceutical Care in Diabetic Neuropathy
NCT05172947Completed
- Sponsor
- University of Sulaimani
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of resveratrol in diabetic neuropathy, sponsored by University of Sulaimani. Started Dec 2021; status: completed.
02
Drugs
resveratrol
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT05172947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05172947.